Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
NCT05363488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2023-04-03
Summary
This study will describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia (CML) used in a real world clinical practice setting.
Conditions
- Myeloid Leukemia
Interventions
- DRUG
-
Bosutinib
Patients receiving bosutinib treatment
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-08
- Primary Completion
- 2021-10-08
- Completion
- 2021-10-08
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety And Efficacy Of Bosutinib
NCT02501330 ·Status: COMPLETED
-
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
NCT02228382 ·Status: TERMINATED ·Phase: PHASE4
-
Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure
NCT02906696 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
NCT06297161 ·Status: RECRUITING
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
NCT00574873 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients
NCT04793399 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects
NCT01374139 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
NCT01254188 ·Status: COMPLETED ·Phase: PHASE3
-
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
NCT04258943 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Bosutinib in Elderly Chronic Myeloid Leukemia
NCT02810990 ·Status: COMPLETED ·Phase: PHASE2
-
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
NCT05734053 ·Status: COMPLETED
-
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT03509896 ·Status: COMPLETED
-
A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT02130557 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
NCT05756322 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
NCT02071225 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
NCT00261846 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
NCT00621244 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma
NCT00532389 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT05687032 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
NCT00449761 ·Status: TERMINATED ·Phase: PHASE2
-
Palatability (Taste) of Oral Formulations of Bosutinib
NCT03747679 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
NCT03435848 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
NCT00836043 ·Status: TERMINATED
-
Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias
NCT00811070 ·Status: COMPLETED ·Phase: PHASE2